Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
EN | CN

You are here:Home-Chemical Inhibitors & Agonists-Immunology/Inflammation-NOD-like Receptor (NLR)-GDC-2394
GDC-2394

Chemical Structure : GDC-2394

CAS No.: 2238822-07-4

GDC-2394 (GDC2394, GDC 2394)

Catalog No.: PC-49396Not For Human Use, Lab Use Only.

GDC-2394 (GDC2394) is a potent and selective NLRP3 inhibitor with IC50 of 5.4 nM (IL-1β inhibition in PBMCs).

Packing Price Stock Quantity
2 mg $258 In stock
5 mg $398 In stock
10 mg $588 In stock
25 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

GDC-2394 (GDC2394) is a potent and selective NLRP3 inhibitor with IC50 of 5.4 nM (IL-1β inhibition in PBMCs).
GDC-2394 inhibits NLRP3-induced caspase-1 activity with IC50 of 51 nM in in THP1 cells, but does not inhibit NLRC4-dependent inflammasome activation.
GDC-2394 inhibits NLRP3-dependent IL-1β release from mouse bone marrow-derived macrophages (BMDMs) with IC50 of 63 nM.
GDC-2394 inhibits LPS plus nigericin-induced ASC speck formation in THP-1 cells with IC50 of 48 nM.
GDC-2394 inhibits production of IL-1β in human and mouse WB in response to LPS priming and activation by ATP, and also LPS priming and activation by MSU crystals, calcium pyrophosphate dehydrate, and cholesterol crystals in HWB and macrophages.
GDC-2394 (25 mg/kg) significantly reduces joint swelling and pain scores, comparable to that achieved by IL-1β blockade, in rodent model of gouty arthritis induced by intra-articular injection of MSU crystals.

Physicochemical Properties

M.Wt 431.511
Formula C20H25N5O4S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

(S)-N-((1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)carbamoyl)-6-(methylamino)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-3-sulfonamide

References

1. Christopher McBride, et al. J Med Chem. 2022 Oct 24. doi: 10.1021/acs.jmedchem.2c01250.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: